Correction: Relevance of tumor boards for the inclusion of patients in oncological clinical trials.
Saved in:
| Title: | Correction: Relevance of tumor boards for the inclusion of patients in oncological clinical trials. |
|---|---|
| Authors: | Dapper H; Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. hendrik-dapper@gmx.de., Dantes M; Department of Radiation Oncology, Comprehensive Cancer Center Munich, University Hospital Munich, LMU Munich, Munich, Germany. mauricedantes@web.de., Herschbach P; Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Algül H; Department of Internal Medicine II, Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Heinemann V; Comprehensive Cancer Center München, Institute for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, Munich, Bavaria, Germany. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2025 Jan 18; Vol. 151 (1), pp. 40. Date of Electronic Publication: 2025 Jan 18. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
